Biosimilar medicines in Australia: On-demand webinar for Pharmacists

Hear from a panel of leading Australian pharmacists as they discuss their views and insights around the use of biosimilar medicines 

This activity will take approximately one hour to complete and includes reflection questions.

Upon completion of this activity, participants will be able to:


Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines


Explain to patients what a biosimilar medicine is, why it is different to a generic medicine, and their therapeutic equivalence to the reference biological product


Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system

This activity has been accredited for 1 hour of Group 1 CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan.

Accreditation number: CX20070